nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Vandetanib—thyroid cancer	0.216	0.277	CbGbCtD
Mifepristone—ABCC1—Epirubicin—thyroid cancer	0.148	0.191	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—thyroid cancer	0.0788	0.101	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0642	0.0825	CbGbCtD
Mifepristone—CYP3A7—Sorafenib—thyroid cancer	0.0642	0.0825	CbGbCtD
Mifepristone—CYP3A5—Sorafenib—thyroid cancer	0.0482	0.0619	CbGbCtD
Mifepristone—ABCB1—Sorafenib—thyroid cancer	0.0314	0.0403	CbGbCtD
Mifepristone—CYP3A4—Vandetanib—thyroid cancer	0.0312	0.04	CbGbCtD
Mifepristone—CYP2D6—Sorafenib—thyroid cancer	0.0295	0.0379	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—thyroid cancer	0.019	0.0244	CbGbCtD
Mifepristone—CYP3A4—Sorafenib—thyroid cancer	0.0188	0.0241	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—thyroid cancer	0.0179	0.023	CbGbCtD
Mifepristone—CYP3A4—Doxorubicin—thyroid cancer	0.0114	0.0146	CbGbCtD
Mifepristone—Blood potassium decreased—Vandetanib—thyroid cancer	0.00794	0.0537	CcSEcCtD
Mifepristone—Blood potassium decreased—Sorafenib—thyroid cancer	0.00535	0.0362	CcSEcCtD
Mifepristone—Gastrooesophageal reflux disease—Sorafenib—thyroid cancer	0.00225	0.0153	CcSEcCtD
Mifepristone—Hypoglycaemia—Vandetanib—thyroid cancer	0.00224	0.0152	CcSEcCtD
Mifepristone—Hypokalaemia—Vandetanib—thyroid cancer	0.00199	0.0135	CcSEcCtD
Mifepristone—Nasopharyngitis—Vandetanib—thyroid cancer	0.00196	0.0133	CcSEcCtD
Mifepristone—Musculoskeletal chest pain—Epirubicin—thyroid cancer	0.00194	0.0131	CcSEcCtD
Mifepristone—Musculoskeletal chest pain—Doxorubicin—thyroid cancer	0.00179	0.0122	CcSEcCtD
Mifepristone—Erythema nodosum—Epirubicin—thyroid cancer	0.00174	0.0118	CcSEcCtD
Mifepristone—Infestation NOS—Vandetanib—thyroid cancer	0.00169	0.0114	CcSEcCtD
Mifepristone—Infestation—Vandetanib—thyroid cancer	0.00169	0.0114	CcSEcCtD
Mifepristone—Erythema nodosum—Doxorubicin—thyroid cancer	0.00161	0.0109	CcSEcCtD
Mifepristone—Sinusitis—Vandetanib—thyroid cancer	0.00158	0.0107	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00157	0.0106	CcSEcCtD
Mifepristone—Haemoglobin—Vandetanib—thyroid cancer	0.00152	0.0103	CcSEcCtD
Mifepristone—Haemorrhage—Vandetanib—thyroid cancer	0.00152	0.0103	CcSEcCtD
Mifepristone—Pain in extremity—Sorafenib—thyroid cancer	0.00148	0.01	CcSEcCtD
Mifepristone—Angiopathy—Vandetanib—thyroid cancer	0.00137	0.00931	CcSEcCtD
Mifepristone—Mediastinal disorder—Vandetanib—thyroid cancer	0.00137	0.00924	CcSEcCtD
Mifepristone—Hypokalaemia—Sorafenib—thyroid cancer	0.00134	0.0091	CcSEcCtD
Mifepristone—Breast disorder—Sorafenib—thyroid cancer	0.00134	0.00904	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00133	0.00901	CcSEcCtD
Mifepristone—Mental disorder—Vandetanib—thyroid cancer	0.00133	0.00899	CcSEcCtD
Mifepristone—Nasopharyngitis—Sorafenib—thyroid cancer	0.00132	0.00894	CcSEcCtD
Mifepristone—Malnutrition—Vandetanib—thyroid cancer	0.00132	0.00893	CcSEcCtD
Mifepristone—Muscle spasms—Vandetanib—thyroid cancer	0.00127	0.00858	CcSEcCtD
Mifepristone—Hypertension—Vandetanib—thyroid cancer	0.00114	0.00771	CcSEcCtD
Mifepristone—Infestation NOS—Sorafenib—thyroid cancer	0.00114	0.00771	CcSEcCtD
Mifepristone—Infestation—Sorafenib—thyroid cancer	0.00114	0.00771	CcSEcCtD
Mifepristone—Arthralgia—Vandetanib—thyroid cancer	0.00112	0.0076	CcSEcCtD
Mifepristone—Anxiety—Vandetanib—thyroid cancer	0.00112	0.00758	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00112	0.00755	CcSEcCtD
Mifepristone—Dry mouth—Vandetanib—thyroid cancer	0.0011	0.00743	CcSEcCtD
Mifepristone—Oedema—Vandetanib—thyroid cancer	0.00108	0.00729	CcSEcCtD
Mifepristone—Infection—Vandetanib—thyroid cancer	0.00107	0.00724	CcSEcCtD
Mifepristone—Nervous system disorder—Vandetanib—thyroid cancer	0.00106	0.00715	CcSEcCtD
Mifepristone—Skin disorder—Vandetanib—thyroid cancer	0.00105	0.00708	CcSEcCtD
Mifepristone—Haemoglobin—Sorafenib—thyroid cancer	0.00103	0.00695	CcSEcCtD
Mifepristone—Haemorrhage—Sorafenib—thyroid cancer	0.00102	0.00692	CcSEcCtD
Mifepristone—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.00102	0.00688	CcSEcCtD
Mifepristone—Connective tissue disorder—Sorafenib—thyroid cancer	0.001	0.0068	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000981	0.00664	CcSEcCtD
Mifepristone—Insomnia—Vandetanib—thyroid cancer	0.000974	0.00659	CcSEcCtD
Mifepristone—Dyspnoea—Vandetanib—thyroid cancer	0.00096	0.0065	CcSEcCtD
Mifepristone—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.00094	0.00637	CcSEcCtD
Mifepristone—Decreased appetite—Vandetanib—thyroid cancer	0.000936	0.00633	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000929	0.00629	CcSEcCtD
Mifepristone—Fatigue—Vandetanib—thyroid cancer	0.000928	0.00628	CcSEcCtD
Mifepristone—Angiopathy—Sorafenib—thyroid cancer	0.000927	0.00628	CcSEcCtD
Mifepristone—Mediastinal disorder—Sorafenib—thyroid cancer	0.000921	0.00624	CcSEcCtD
Mifepristone—Pain—Vandetanib—thyroid cancer	0.00092	0.00623	CcSEcCtD
Mifepristone—Constipation—Vandetanib—thyroid cancer	0.00092	0.00623	CcSEcCtD
Mifepristone—Mental disorder—Sorafenib—thyroid cancer	0.000895	0.00606	CcSEcCtD
Mifepristone—Malnutrition—Sorafenib—thyroid cancer	0.00089	0.00602	CcSEcCtD
Mifepristone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00088	0.00596	CcSEcCtD
Mifepristone—Muscle spasms—Sorafenib—thyroid cancer	0.000855	0.00579	CcSEcCtD
Mifepristone—Body temperature increased—Vandetanib—thyroid cancer	0.000851	0.00576	CcSEcCtD
Mifepristone—Abdominal pain—Vandetanib—thyroid cancer	0.000851	0.00576	CcSEcCtD
Mifepristone—Angioedema—Sorafenib—thyroid cancer	0.000813	0.0055	CcSEcCtD
Mifepristone—Asthenia—Vandetanib—thyroid cancer	0.000772	0.00523	CcSEcCtD
Mifepristone—Hypertension—Sorafenib—thyroid cancer	0.000768	0.0052	CcSEcCtD
Mifepristone—Pruritus—Vandetanib—thyroid cancer	0.000762	0.00516	CcSEcCtD
Mifepristone—Myalgia—Sorafenib—thyroid cancer	0.000757	0.00513	CcSEcCtD
Mifepristone—Arthralgia—Sorafenib—thyroid cancer	0.000757	0.00513	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000752	0.00509	CcSEcCtD
Mifepristone—Dry mouth—Sorafenib—thyroid cancer	0.000741	0.00502	CcSEcCtD
Mifepristone—Diarrhoea—Vandetanib—thyroid cancer	0.000736	0.00499	CcSEcCtD
Mifepristone—Infection—Sorafenib—thyroid cancer	0.000721	0.00488	CcSEcCtD
Mifepristone—Nervous system disorder—Sorafenib—thyroid cancer	0.000712	0.00482	CcSEcCtD
Mifepristone—Dizziness—Vandetanib—thyroid cancer	0.000712	0.00482	CcSEcCtD
Mifepristone—Skin disorder—Sorafenib—thyroid cancer	0.000705	0.00477	CcSEcCtD
Mifepristone—Anorexia—Sorafenib—thyroid cancer	0.000692	0.00469	CcSEcCtD
Mifepristone—Vomiting—Vandetanib—thyroid cancer	0.000684	0.00463	CcSEcCtD
Mifepristone—Rash maculo-papular—Epirubicin—thyroid cancer	0.000684	0.00463	CcSEcCtD
Mifepristone—Rash—Vandetanib—thyroid cancer	0.000679	0.00459	CcSEcCtD
Mifepristone—Dermatitis—Vandetanib—thyroid cancer	0.000678	0.00459	CcSEcCtD
Mifepristone—Headache—Vandetanib—thyroid cancer	0.000674	0.00457	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000662	0.00448	CcSEcCtD
Mifepristone—Dyspnoea—Sorafenib—thyroid cancer	0.000647	0.00438	CcSEcCtD
Mifepristone—Nausea—Vandetanib—thyroid cancer	0.000639	0.00433	CcSEcCtD
Mifepristone—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000633	0.00428	CcSEcCtD
Mifepristone—Decreased appetite—Sorafenib—thyroid cancer	0.000631	0.00427	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000627	0.00424	CcSEcCtD
Mifepristone—Fatigue—Sorafenib—thyroid cancer	0.000626	0.00424	CcSEcCtD
Mifepristone—Pain—Sorafenib—thyroid cancer	0.000621	0.0042	CcSEcCtD
Mifepristone—Constipation—Sorafenib—thyroid cancer	0.000621	0.0042	CcSEcCtD
Mifepristone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000594	0.00402	CcSEcCtD
Mifepristone—Hot flush—Epirubicin—thyroid cancer	0.000584	0.00395	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000579	0.00392	CcSEcCtD
Mifepristone—Menopausal symptoms—Epirubicin—thyroid cancer	0.000579	0.00392	CcSEcCtD
Mifepristone—Urticaria—Sorafenib—thyroid cancer	0.000577	0.00391	CcSEcCtD
Mifepristone—Body temperature increased—Sorafenib—thyroid cancer	0.000574	0.00389	CcSEcCtD
Mifepristone—Abdominal pain—Sorafenib—thyroid cancer	0.000574	0.00389	CcSEcCtD
Mifepristone—Hypoglycaemia—Epirubicin—thyroid cancer	0.000559	0.00379	CcSEcCtD
Mifepristone—Pain in extremity—Epirubicin—thyroid cancer	0.000546	0.0037	CcSEcCtD
Mifepristone—Hot flush—Doxorubicin—thyroid cancer	0.00054	0.00366	CcSEcCtD
Mifepristone—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000535	0.00362	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000535	0.00362	CcSEcCtD
Mifepristone—Hypersensitivity—Sorafenib—thyroid cancer	0.000535	0.00362	CcSEcCtD
Mifepristone—Asthenia—Sorafenib—thyroid cancer	0.000521	0.00353	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000518	0.0035	CcSEcCtD
Mifepristone—Pruritus—Sorafenib—thyroid cancer	0.000514	0.00348	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—thyroid cancer	0.000505	0.00342	CcSEcCtD
Mifepristone—Hypokalaemia—Epirubicin—thyroid cancer	0.000497	0.00336	CcSEcCtD
Mifepristone—Diarrhoea—Sorafenib—thyroid cancer	0.000497	0.00336	CcSEcCtD
Mifepristone—Breast disorder—Epirubicin—thyroid cancer	0.000493	0.00334	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000492	0.00333	CcSEcCtD
Mifepristone—Nasopharyngitis—Epirubicin—thyroid cancer	0.000488	0.00331	CcSEcCtD
Mifepristone—Muscular weakness—Epirubicin—thyroid cancer	0.000482	0.00326	CcSEcCtD
Mifepristone—Dizziness—Sorafenib—thyroid cancer	0.00048	0.00325	CcSEcCtD
Mifepristone—Vomiting—Sorafenib—thyroid cancer	0.000462	0.00313	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—thyroid cancer	0.00046	0.00311	CcSEcCtD
Mifepristone—Rash—Sorafenib—thyroid cancer	0.000458	0.0031	CcSEcCtD
Mifepristone—Dermatitis—Sorafenib—thyroid cancer	0.000457	0.0031	CcSEcCtD
Mifepristone—Breast disorder—Doxorubicin—thyroid cancer	0.000457	0.00309	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000455	0.00308	CcSEcCtD
Mifepristone—Headache—Sorafenib—thyroid cancer	0.000455	0.00308	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000452	0.00306	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—thyroid cancer	0.000446	0.00302	CcSEcCtD
Mifepristone—AR—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.000438	0.00594	CbGpPWpGaD
Mifepristone—Nausea—Sorafenib—thyroid cancer	0.000431	0.00292	CcSEcCtD
Mifepristone—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000431	0.00584	CbGpPWpGaD
Mifepristone—Infestation NOS—Epirubicin—thyroid cancer	0.000421	0.00285	CcSEcCtD
Mifepristone—Infestation—Epirubicin—thyroid cancer	0.000421	0.00285	CcSEcCtD
Mifepristone—AR—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00042	0.00569	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.000416	0.00565	CbGpPWpGaD
Mifepristone—AR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000414	0.00562	CbGpPWpGaD
Mifepristone—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.000398	0.00539	CbGpPWpGaD
Mifepristone—Sinusitis—Epirubicin—thyroid cancer	0.000395	0.00267	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—thyroid cancer	0.000389	0.00264	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—thyroid cancer	0.000389	0.00264	CcSEcCtD
Mifepristone—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000388	0.00527	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDK1—thyroid cancer	0.000388	0.00525	CbGpPWpGaD
Mifepristone—Haemoglobin—Epirubicin—thyroid cancer	0.00038	0.00257	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—thyroid cancer	0.000378	0.00256	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—thyroid cancer	0.000372	0.00252	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000371	0.00251	CcSEcCtD
Mifepristone—AR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000369	0.005	CbGpPWpGaD
Mifepristone—Sinusitis—Doxorubicin—thyroid cancer	0.000365	0.00247	CcSEcCtD
Mifepristone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000363	0.00492	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—thyroid cancer	0.000356	0.00482	CbGpPWpGaD
Mifepristone—Haemoglobin—Doxorubicin—thyroid cancer	0.000351	0.00238	CcSEcCtD
Mifepristone—PGR—Generic Transcription Pathway—THRB—thyroid cancer	0.00035	0.00475	CbGpPWpGaD
Mifepristone—Haemorrhage—Doxorubicin—thyroid cancer	0.000349	0.00237	CcSEcCtD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000349	0.00473	CbGpPWpGaD
Mifepristone—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.000348	0.00472	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000346	0.00469	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000345	0.00467	CbGpPWpGaD
Mifepristone—Oedema peripheral—Doxorubicin—thyroid cancer	0.000344	0.00233	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000343	0.00233	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—thyroid cancer	0.000343	0.00232	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—thyroid cancer	0.00034	0.0023	CcSEcCtD
Mifepristone—Chills—Epirubicin—thyroid cancer	0.000339	0.00229	CcSEcCtD
Mifepristone—AR—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000332	0.0045	CbGpPWpGaD
Mifepristone—Mental disorder—Epirubicin—thyroid cancer	0.000331	0.00224	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—thyroid cancer	0.000329	0.00223	CcSEcCtD
Mifepristone—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000323	0.00438	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000322	0.00437	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000319	0.00432	CbGpPWpGaD
Mifepristone—Back pain—Epirubicin—thyroid cancer	0.000318	0.00215	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—thyroid cancer	0.000317	0.00215	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—thyroid cancer	0.000316	0.00214	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000315	0.00213	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000314	0.00426	CbGpPWpGaD
Mifepristone—Chills—Doxorubicin—thyroid cancer	0.000314	0.00212	CcSEcCtD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000311	0.00422	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—NRG1—thyroid cancer	0.000311	0.00422	CbGpPWpGaD
Mifepristone—Mental disorder—Doxorubicin—thyroid cancer	0.000306	0.00207	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000305	0.00207	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—thyroid cancer	0.000304	0.00206	CcSEcCtD
Mifepristone—Malaise—Epirubicin—thyroid cancer	0.000297	0.00201	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—thyroid cancer	0.000294	0.00199	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—thyroid cancer	0.000292	0.00198	CcSEcCtD
Mifepristone—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000287	0.00389	CbGpPWpGaD
Mifepristone—Hypertension—Epirubicin—thyroid cancer	0.000284	0.00192	CcSEcCtD
Mifepristone—ABCC1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000284	0.00385	CbGpPWpGaD
Mifepristone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000282	0.00191	CcSEcCtD
Mifepristone—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00028	0.0038	CbGpPWpGaD
Mifepristone—Myalgia—Epirubicin—thyroid cancer	0.00028	0.0019	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—thyroid cancer	0.00028	0.0019	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—thyroid cancer	0.000279	0.00189	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000278	0.00188	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—thyroid cancer	0.000277	0.00187	CcSEcCtD
Mifepristone—AR—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.000276	0.00375	CbGpPWpGaD
Mifepristone—Malaise—Doxorubicin—thyroid cancer	0.000274	0.00186	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—thyroid cancer	0.000274	0.00185	CcSEcCtD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000272	0.00368	CbGpPWpGaD
Mifepristone—Oedema—Epirubicin—thyroid cancer	0.000268	0.00182	CcSEcCtD
Mifepristone—AR—Generic Transcription Pathway—THRB—thyroid cancer	0.000267	0.00362	CbGpPWpGaD
Mifepristone—Infection—Epirubicin—thyroid cancer	0.000267	0.0018	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—thyroid cancer	0.000263	0.00178	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—thyroid cancer	0.000263	0.00178	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—thyroid cancer	0.000261	0.00176	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—thyroid cancer	0.000259	0.00175	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—thyroid cancer	0.000259	0.00175	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—thyroid cancer	0.000258	0.00175	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000257	0.00174	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—thyroid cancer	0.000256	0.00173	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—thyroid cancer	0.000256	0.00173	CcSEcCtD
Mifepristone—AR—Coregulation of Androgen receptor activity—CCND1—thyroid cancer	0.000255	0.00346	CbGpPWpGaD
Mifepristone—Dry mouth—Doxorubicin—thyroid cancer	0.000253	0.00171	CcSEcCtD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000252	0.00342	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000252	0.00341	CbGpPWpGaD
Mifepristone—Hypotension—Epirubicin—thyroid cancer	0.000251	0.0017	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—thyroid cancer	0.000248	0.00168	CcSEcCtD
Mifepristone—Infection—Doxorubicin—thyroid cancer	0.000247	0.00167	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000244	0.00166	CcSEcCtD
Mifepristone—AR—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.000244	0.00331	CbGpPWpGaD
Mifepristone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000243	0.00165	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—thyroid cancer	0.000243	0.00164	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—thyroid cancer	0.000241	0.00163	CcSEcCtD
Mifepristone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000239	0.00324	CbGpPWpGaD
Mifepristone—Dyspnoea—Epirubicin—thyroid cancer	0.000239	0.00162	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—thyroid cancer	0.000239	0.00162	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—thyroid cancer	0.000237	0.0016	CcSEcCtD
Mifepristone—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.000236	0.00319	CbGpPWpGaD
Mifepristone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000234	0.00317	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—TRIM33—thyroid cancer	0.000233	0.00316	CbGpPWpGaD
Mifepristone—Decreased appetite—Epirubicin—thyroid cancer	0.000233	0.00158	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—thyroid cancer	0.000232	0.00157	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000232	0.00157	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—thyroid cancer	0.000231	0.00157	CcSEcCtD
Mifepristone—Constipation—Epirubicin—thyroid cancer	0.000229	0.00155	CcSEcCtD
Mifepristone—Pain—Epirubicin—thyroid cancer	0.000229	0.00155	CcSEcCtD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000228	0.00309	CbGpPWpGaD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000226	0.00153	CcSEcCtD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000226	0.00306	CbGpPWpGaD
Mifepristone—Insomnia—Doxorubicin—thyroid cancer	0.000225	0.00152	CcSEcCtD
Mifepristone—PGR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000222	0.00302	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000221	0.003	CbGpPWpGaD
Mifepristone—Dyspnoea—Doxorubicin—thyroid cancer	0.000221	0.0015	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—thyroid cancer	0.000221	0.0015	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—thyroid cancer	0.000221	0.00149	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000219	0.00149	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—thyroid cancer	0.000216	0.00146	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000214	0.00145	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—thyroid cancer	0.000214	0.00145	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—thyroid cancer	0.000213	0.00144	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—thyroid cancer	0.000212	0.00144	CcSEcCtD
Mifepristone—Pain—Doxorubicin—thyroid cancer	0.000212	0.00144	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—thyroid cancer	0.000212	0.00144	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—thyroid cancer	0.000212	0.00144	CcSEcCtD
Mifepristone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000211	0.00286	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—thyroid cancer	0.000206	0.00279	CbGpPWpGaD
Mifepristone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000205	0.00139	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000203	0.00137	CcSEcCtD
Mifepristone—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.000202	0.00274	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000199	0.0027	CbGpPWpGaD
Mifepristone—Hypersensitivity—Epirubicin—thyroid cancer	0.000198	0.00134	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—thyroid cancer	0.000197	0.00134	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—thyroid cancer	0.000196	0.00133	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—thyroid cancer	0.000196	0.00133	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—thyroid cancer	0.000193	0.0013	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—thyroid cancer	0.00019	0.00129	CcSEcCtD
Mifepristone—AR—Androgen receptor signaling pathway—CCND1—thyroid cancer	0.000189	0.00256	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—RXRA—thyroid cancer	0.000185	0.00251	CbGpPWpGaD
Mifepristone—Diarrhoea—Epirubicin—thyroid cancer	0.000184	0.00124	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000183	0.00124	CcSEcCtD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.000182	0.00247	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—PTEN—thyroid cancer	0.000182	0.00247	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000179	0.00243	CbGpPWpGaD
Mifepristone—Asthenia—Doxorubicin—thyroid cancer	0.000178	0.00121	CcSEcCtD
Mifepristone—AR—Gene Expression—TRIM33—thyroid cancer	0.000178	0.00241	CbGpPWpGaD
Mifepristone—Dizziness—Epirubicin—thyroid cancer	0.000177	0.0012	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—thyroid cancer	0.000176	0.00119	CcSEcCtD
Mifepristone—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000175	0.00237	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000173	0.00235	CbGpPWpGaD
Mifepristone—Vomiting—Epirubicin—thyroid cancer	0.000171	0.00116	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—thyroid cancer	0.00017	0.00115	CcSEcCtD
Mifepristone—AR—Generic Transcription Pathway—MEN1—thyroid cancer	0.00017	0.0023	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000169	0.0023	CbGpPWpGaD
Mifepristone—Rash—Epirubicin—thyroid cancer	0.000169	0.00115	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—thyroid cancer	0.000169	0.00114	CcSEcCtD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000169	0.00229	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—THRB—thyroid cancer	0.000169	0.00229	CbGpPWpGaD
Mifepristone—Headache—Epirubicin—thyroid cancer	0.000168	0.00114	CcSEcCtD
Mifepristone—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000167	0.00227	CbGpPWpGaD
Mifepristone—Dizziness—Doxorubicin—thyroid cancer	0.000164	0.00111	CcSEcCtD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000162	0.00219	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CALCB—thyroid cancer	0.00016	0.00217	CbGpPWpGaD
Mifepristone—Nausea—Epirubicin—thyroid cancer	0.000159	0.00108	CcSEcCtD
Mifepristone—ABCC1—Disease—TRIM24—thyroid cancer	0.000159	0.00215	CbGpPWpGaD
Mifepristone—Vomiting—Doxorubicin—thyroid cancer	0.000158	0.00107	CcSEcCtD
Mifepristone—Rash—Doxorubicin—thyroid cancer	0.000157	0.00106	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—thyroid cancer	0.000156	0.00106	CcSEcCtD
Mifepristone—ABCC1—Metabolism—MINPP1—thyroid cancer	0.000156	0.00212	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PTEN—thyroid cancer	0.000156	0.00211	CbGpPWpGaD
Mifepristone—Headache—Doxorubicin—thyroid cancer	0.000156	0.00105	CcSEcCtD
Mifepristone—PGR—Signaling Pathways—TRIM33—thyroid cancer	0.000152	0.00206	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000151	0.00205	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CHST14—thyroid cancer	0.000149	0.00202	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000149	0.00202	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000149	0.00202	CbGpPWpGaD
Mifepristone—Nausea—Doxorubicin—thyroid cancer	0.000147	0.000998	CcSEcCtD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000145	0.00196	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000144	0.00195	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—AKT1—thyroid cancer	0.000142	0.00192	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TRIM33—thyroid cancer	0.000141	0.00192	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00014	0.0019	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—NRAS—thyroid cancer	0.000139	0.00188	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MINPP1—thyroid cancer	0.000136	0.00185	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000135	0.00183	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—RXRA—thyroid cancer	0.000134	0.00182	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NDUFA13—thyroid cancer	0.000133	0.0018	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000129	0.00174	CbGpPWpGaD
Mifepristone—AR—Gene Expression—THRB—thyroid cancer	0.000129	0.00174	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CHST14—thyroid cancer	0.000125	0.00169	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000124	0.00168	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000123	0.00167	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000123	0.00167	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000121	0.00165	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—KRAS—thyroid cancer	0.00012	0.00162	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000119	0.00162	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000117	0.00159	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NDUFA13—thyroid cancer	0.000116	0.00157	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000114	0.00155	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—TPR—thyroid cancer	0.000114	0.00154	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000113	0.00154	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000113	0.00154	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000113	0.00153	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CHST14—thyroid cancer	0.000109	0.00148	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MEN1—thyroid cancer	0.000107	0.00145	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—AKT1—thyroid cancer	0.000105	0.00142	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000102	0.00139	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—HRAS—thyroid cancer	0.000102	0.00138	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TCF7L1—thyroid cancer	0.000101	0.00137	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000101	0.00136	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—HPGD—thyroid cancer	0.000101	0.00136	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.89e-05	0.00134	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MINPP1—thyroid cancer	9.85e-05	0.00134	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—THRB—thyroid cancer	9.75e-05	0.00132	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—RXRA—thyroid cancer	9.53e-05	0.00129	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TCF7L1—thyroid cancer	9.43e-05	0.00128	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—PPARG—thyroid cancer	9.4e-05	0.00127	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	9.3e-05	0.00126	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.24e-05	0.00125	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	9.16e-05	0.00124	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—AKT1—thyroid cancer	8.98e-05	0.00122	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—HPGD—thyroid cancer	8.78e-05	0.00119	CbGpPWpGaD
Mifepristone—AR—Gene Expression—TPR—thyroid cancer	8.68e-05	0.00118	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	8.6e-05	0.00117	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	8.59e-05	0.00116	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	8.5e-05	0.00115	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NDUFA13—thyroid cancer	8.38e-05	0.00114	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.17e-05	0.00111	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MEN1—thyroid cancer	8.16e-05	0.00111	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	8.14e-05	0.0011	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CHST14—thyroid cancer	7.87e-05	0.00107	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.76e-05	0.00105	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.59e-05	0.00103	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MINPP1—thyroid cancer	7.43e-05	0.00101	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TSHR—thyroid cancer	7.41e-05	0.001	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PRKAR1A—thyroid cancer	7.29e-05	0.000988	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—RXRA—thyroid cancer	7.17e-05	0.000971	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—PPARG—thyroid cancer	7.16e-05	0.00097	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MINPP1—thyroid cancer	7e-05	0.000949	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MEN1—thyroid cancer	6.96e-05	0.000944	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TPR—thyroid cancer	6.9e-05	0.000936	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	6.88e-05	0.000932	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PRKAR1A—thyroid cancer	6.79e-05	0.000921	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.75e-05	0.000915	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—TPR—thyroid cancer	6.59e-05	0.000893	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MEN1—thyroid cancer	6.49e-05	0.00088	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HPGD—thyroid cancer	6.35e-05	0.00086	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NDUFA13—thyroid cancer	6.32e-05	0.000857	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTCH1—thyroid cancer	6.3e-05	0.000854	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.23e-05	0.000845	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MEN1—thyroid cancer	6.19e-05	0.000839	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NDUFA13—thyroid cancer	5.96e-05	0.000807	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CHST14—thyroid cancer	5.94e-05	0.000805	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	5.87e-05	0.000796	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	5.87e-05	0.000796	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TPR—thyroid cancer	5.78e-05	0.000784	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.78e-05	0.000783	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SST—thyroid cancer	5.76e-05	0.000781	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.7e-05	0.000772	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PRKAR1A—thyroid cancer	5.69e-05	0.000771	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CHST14—thyroid cancer	5.6e-05	0.000759	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CALCA—thyroid cancer	5.55e-05	0.000752	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RXRA—thyroid cancer	5.46e-05	0.00074	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.43e-05	0.000737	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	5.43e-05	0.000736	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CALCA—thyroid cancer	5.17e-05	0.000701	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.16e-05	0.000699	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TPR—thyroid cancer	5.04e-05	0.000684	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDK1—thyroid cancer	5.02e-05	0.00068	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	4.96e-05	0.000673	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HPGD—thyroid cancer	4.79e-05	0.000649	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDK1—thyroid cancer	4.68e-05	0.000634	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.62e-05	0.000626	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.58e-05	0.000621	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—PPARG—thyroid cancer	4.52e-05	0.000613	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HPGD—thyroid cancer	4.51e-05	0.000612	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.4e-05	0.000596	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC5A5—thyroid cancer	4.33e-05	0.000587	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.18e-05	0.000566	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RXRA—thyroid cancer	4.14e-05	0.000561	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.06e-05	0.00055	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.03e-05	0.000546	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRG1—thyroid cancer	4.03e-05	0.000546	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.89e-05	0.000528	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.78e-05	0.000512	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRG1—thyroid cancer	3.76e-05	0.000509	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.69e-05	0.000501	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CHST14—thyroid cancer	3.66e-05	0.000496	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TPR—thyroid cancer	3.65e-05	0.000494	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—RXRA—thyroid cancer	3.64e-05	0.000493	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TERT—thyroid cancer	3.62e-05	0.00049	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.59e-05	0.000486	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.54e-05	0.000479	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HIF1A—thyroid cancer	3.46e-05	0.000469	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—thyroid cancer	3.45e-05	0.000467	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TERT—thyroid cancer	3.37e-05	0.000457	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HIF1A—thyroid cancer	3.22e-05	0.000437	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—RXRA—thyroid cancer	3.17e-05	0.00043	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.09e-05	0.000419	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HPGD—thyroid cancer	2.95e-05	0.0004	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BRAF—thyroid cancer	2.86e-05	0.000388	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TPR—thyroid cancer	2.75e-05	0.000373	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.75e-05	0.000373	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.73e-05	0.00037	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.71e-05	0.000367	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BRAF—thyroid cancer	2.67e-05	0.000362	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—thyroid cancer	2.62e-05	0.000354	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TPR—thyroid cancer	2.59e-05	0.000351	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.55e-05	0.000346	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.32e-05	0.000315	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—thyroid cancer	2.3e-05	0.000311	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—RXRA—thyroid cancer	2.29e-05	0.000311	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—thyroid cancer	2.16e-05	0.000292	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—thyroid cancer	2.09e-05	0.000283	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.06e-05	0.000279	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—thyroid cancer	2.02e-05	0.000274	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—thyroid cancer	2e-05	0.000271	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.94e-05	0.000263	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—thyroid cancer	1.88e-05	0.000255	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—thyroid cancer	1.81e-05	0.000245	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—thyroid cancer	1.8e-05	0.000244	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—thyroid cancer	1.79e-05	0.000242	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—RXRA—thyroid cancer	1.73e-05	0.000235	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TPR—thyroid cancer	1.69e-05	0.00023	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—thyroid cancer	1.68e-05	0.000227	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.67e-05	0.000226	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—RXRA—thyroid cancer	1.63e-05	0.000221	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.58e-05	0.000214	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—thyroid cancer	1.58e-05	0.000214	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—thyroid cancer	1.55e-05	0.00021	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—thyroid cancer	1.45e-05	0.000196	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—thyroid cancer	1.44e-05	0.000196	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—thyroid cancer	1.38e-05	0.000187	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—thyroid cancer	1.37e-05	0.000186	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—thyroid cancer	1.36e-05	0.000185	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—thyroid cancer	1.32e-05	0.000179	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.27e-05	0.000172	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—thyroid cancer	1.23e-05	0.000166	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—thyroid cancer	1.16e-05	0.000158	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.14e-05	0.000154	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—thyroid cancer	1.09e-05	0.000148	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—thyroid cancer	1.08e-05	0.000147	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RXRA—thyroid cancer	1.07e-05	0.000144	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—thyroid cancer	1.03e-05	0.00014	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—thyroid cancer	1.03e-05	0.00014	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—thyroid cancer	9.93e-06	0.000135	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—thyroid cancer	9.08e-06	0.000123	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—thyroid cancer	8.59e-06	0.000116	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—thyroid cancer	8.1e-06	0.00011	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—thyroid cancer	7.92e-06	0.000107	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—thyroid cancer	7.49e-06	0.000102	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—thyroid cancer	7.06e-06	9.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—thyroid cancer	6.73e-06	9.12e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—thyroid cancer	5.72e-06	7.76e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.29e-06	7.18e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—thyroid cancer	4.62e-06	6.26e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—thyroid cancer	4.32e-06	5.85e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—thyroid cancer	4.07e-06	5.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—thyroid cancer	2.66e-06	3.61e-05	CbGpPWpGaD
